IRadimed CorporationIRMDNASDAQ
Loading
Net Income Growth Recovery in ProgressRecovering
Percentile Rank62
3Y CAGR+29.2%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+29.2%/yr
vs -24.0%/yr prior
Acceleration
+53.2pp
Accelerating
Percentile
P62
Within normal range
vs 3Y Ago
2.2x
Strong expansion
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 15.52% |
| Q3 2025 | -3.42% |
| Q2 2025 | 23.18% |
| Q1 2025 | -8.92% |
| Q4 2024 | 1.93% |
| Q3 2024 | 3.03% |
| Q2 2024 | 18.49% |
| Q1 2024 | -8.88% |
| Q4 2023 | -10.41% |
| Q3 2023 | 21.23% |
| Q2 2023 | 22.72% |
| Q1 2023 | -7.28% |
| Q4 2022 | 7.19% |
| Q3 2022 | 5.74% |
| Q2 2022 | 30.33% |
| Q1 2022 | -36.12% |
| Q4 2021 | 51.10% |
| Q3 2021 | 75.29% |
| Q2 2021 | 5.97% |
| Q1 2021 | 117.57% |
| Q4 2020 | -40.69% |
| Q3 2020 | 150.88% |
| Q2 2020 | -219.39% |
| Q1 2020 | -45.42% |
| Q4 2019 | 32.05% |
| Q3 2019 | 17.52% |
| Q2 2019 | 13.18% |
| Q1 2019 | 8.12% |
| Q4 2018 | -28.88% |
| Q3 2018 | 77.15% |
| Q2 2018 | 61.08% |
| Q1 2018 | 358.07% |
| Q4 2017 | -4.55% |
| Q3 2017 | -46.12% |
| Q2 2017 | 253.03% |
| Q1 2017 | -120.45% |
| Q4 2016 | -26.89% |
| Q3 2016 | -30.06% |
| Q2 2016 | -2.22% |
| Q1 2016 | -5.10% |